362 related articles for article (PubMed ID: 30170706)
1. [The Boston keratoprosthesis in the management of corneal blindness: Indications and limitations].
Stolowy N; Callet M; Beylerian M; Hoffart L; Yin GHW
J Fr Ophtalmol; 2018 Sep; 41(7):642-649. PubMed ID: 30170706
[TBL] [Abstract][Full Text] [Related]
2. [Boston keratoprosthesis type 1].
Harissi-Dagher M; Slim E
J Fr Ophtalmol; 2019 Mar; 42(3):295-302. PubMed ID: 30857801
[TBL] [Abstract][Full Text] [Related]
3. Boston keratoprosthesis type I in the elderly.
Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
[TBL] [Abstract][Full Text] [Related]
4. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
Aldave AJ; Kamal KM; Vo RC; Yu F
Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
[TBL] [Abstract][Full Text] [Related]
5. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
Pujari S; Siddique SS; Dohlman CH; Chodosh J
Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
[TBL] [Abstract][Full Text] [Related]
6. [Alphacor keratoprosthesis: device, surgical technique and clinical outcomes].
Trichet E; Carles G; Matonti F; Proust H; Ridings B; Conrath J; Hoffart L
J Fr Ophtalmol; 2013 May; 36(5):393-401. PubMed ID: 23485351
[TBL] [Abstract][Full Text] [Related]
7. Design and Outcomes of a Novel Keratoprosthesis: Addressing Unmet Needs in End-Stage Cicatricial Corneal Blindness.
Bakshi SK; Graney J; Paschalis EI; Agarwal S; Basu S; Iyer G; Liu C; Srinivasan B; Chodosh J
Cornea; 2020 Apr; 39(4):484-490. PubMed ID: 31724985
[TBL] [Abstract][Full Text] [Related]
8. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
Verdejo-Gómez L; Peláez N; Gris O; Güell JL
Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
[TBL] [Abstract][Full Text] [Related]
9. [Long-term visual outcomes of Boston type I keratoprosthesis in Canada].
Aoun T; Harissi-Dagher M
J Fr Ophtalmol; 2023 Dec; 46(10):1212-1221. PubMed ID: 37867123
[TBL] [Abstract][Full Text] [Related]
10. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
Greiner MA; Li JY; Mannis MJ
Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
[TBL] [Abstract][Full Text] [Related]
11. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
Sejpal K; Yu F; Aldave AJ
Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
[TBL] [Abstract][Full Text] [Related]
12. [Boston Keratoprosthesis with temporal aponeurosis graft: A solution when there seems to be no more].
Moyal L; Adam R; Boumendil J; Meney J; Rodallec T; Akesbi J; Nordmann JP
J Fr Ophtalmol; 2018 Nov; 41(9):830-835. PubMed ID: 30343989
[TBL] [Abstract][Full Text] [Related]
13. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
[TBL] [Abstract][Full Text] [Related]
14. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
Kang JJ; de la Cruz J; Cortina MS
Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
[TBL] [Abstract][Full Text] [Related]
15. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis.
Goldman DR; Hubschman JP; Aldave AJ; Chiang A; Huang JS; Bourges JL; Schwartz SD
Retina; 2013 Mar; 33(3):532-41. PubMed ID: 23073339
[TBL] [Abstract][Full Text] [Related]
16. Five year follow up of biocolonisable microporous fluorocarbon haptic (BIOKOP) keratoprosthesis implantation in patients with high risk of corneal graft failure.
Alió JL; Mulet ME; Haroun H; Merayo J; Ruiz Moreno JM
Br J Ophthalmol; 2004 Dec; 88(12):1585-9. PubMed ID: 15550368
[TBL] [Abstract][Full Text] [Related]
17. Boston type 1 keratoprosthesis: the university of california davis experience.
Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
[TBL] [Abstract][Full Text] [Related]
18. The Boston keratoprosthesis type I in mucous membrane pemphigoid.
Palioura S; Kim B; Dohlman CH; Chodosh J
Cornea; 2013 Jul; 32(7):956-61. PubMed ID: 23538625
[TBL] [Abstract][Full Text] [Related]
19. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
[TBL] [Abstract][Full Text] [Related]
20. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
Shah KJ; Cheung AY; Holland EJ
Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
